Most product decisions are made with 30% confidence and shipped as if they're certain. We flip that. We prove what works before you bet the budget. Small MVPs, real user testing, rapid iteration. You learn 10x faster.
Good products don't start with good ideas. They start with good thinking. We help you think before you build. Product discovery kills certainty. You interview 50 users, not 5. You learn what they actually do, not what they say they do. Then we test your assumption with prototypes. Real prototypes. Clickable. Testable. 40 hours of work, not 40 weeks.
User research, problem validation, competitive analysis, success metrics.
Rapid prototyping, user testing, feedback synthesis, go/no-go decision.
Agile sprints, user feedback loops, weekly releases.
Soft launch, metrics tracking, next iteration planning.
Most corporate innovation programs produce impressive presentations and zero shipped products. The gap between innovation ambition and execution has widened since 2020 — BCG's 2024 Most Innovative Companies report found that 83% of business leaders rate innovation a top-3 priority, yet only 31% rate their organization's performance as strong. That gap exists because most organizations treat innovation as a culture initiative rather than a portfolio management problem. What follows is a structured breakdown of what the evidence says actually works — from how to allocate your R&D budget across risk horizons to which AI tools are compressing the innovation cycle, to the specific metrics that predict whether your program will produce real outcomes.
The single most predictive factor of corporate innovation success is not the quality of individual ideas — it is how well the organization allocates investment across risk levels. McKinsey's Three Horizons model, originally articulated in The Alchemy of Growth (Baghai, Coley, White, 1999) and updated by McKinsey Quarterly in 2023, remains the most widely used portfolio-level diagnostic in enterprise settings. Most organizations fail because they run all three horizons at the same cadence, with the same governance, against the same metrics — guaranteeing that H3 bets are killed early and H2 opportunities are chronically underfunded.
Incremental improvements to existing products and processes. Low risk, high predictability, 12–24 month payoff. AI automation of existing workflows, UI/UX improvements to core products, infrastructure upgrades that reduce cost. The trap: this is where most enterprises concentrate all their innovation investment, because it is the easiest to justify and measure. It is necessary but strategically insufficient — it makes the existing business more efficient without addressing the competitive threats that will eventually erode it. H1 investment should be governed by standard product metrics: revenue impact, cost reduction, customer retention.
New products or markets using existing capabilities. Medium risk, 18–36 month payoff. Expanding an existing product to a new customer segment, building a second product leveraging your core platform, entering an adjacent market where you hold a unique advantage. BCG's Most Innovative Companies data consistently shows that the highest-performing innovators generate the largest share of their innovation ROI from H2, not H3. This is consistently the most underfunded horizon — riskier than H1 but not glamorous enough for executive attention the way H3 moonshots are. DeepLearnHQ take: the teams that create the most H2 value appoint a senior PM — not a committee — as the accountable decision-maker for each H2 bet, with 8–12 week time-boxes and explicit go/no-go gates.
New capabilities, new markets, new business models. High risk, 3–7 year payoff under the original model — though AI and cloud infrastructure have collapsed H3 timelines materially. A startup can now traverse all three horizons in 18 months, and McKinsey's 2023 update acknowledges this. H3 investments should be few, small, and explicitly funded as options rather than commitments. The governance mistake: applying H1 ROI standards to H3 bets. H3 should be measured by learning velocity and assumption invalidation rate, not revenue. Kill at 90 days if the hypothesis is wrong; promote to H2 if validated.
| Horizon | Budget Allocation | Time Horizon | Risk Profile | Primary Success Metric | Governance Model | Most Common Mistake |
|---|---|---|---|---|---|---|
| H1: Core Optimization | 60–70% | 12–24 months | Low | Revenue impact, cost reduction, retention | Standard product sprint governance | Over-allocating at the expense of H2/H3 |
| H2: Adjacent Growth | 20–30% | 18–36 months | Medium | New segment revenue, pilot adoption rate | 8–12 week time-boxes with go/no-go gates | Chronic underfunding; no dedicated ownership |
| H3: Transformative Bets | 5–15% | 3–7 years (compressed by AI) | High | Assumptions invalidated, options acquired | Innovation accounting; 90-day kill criteria | Applying H1 ROI standards; too many active bets |
The second most important structural decision after portfolio allocation is how individual innovation bets are governed. Two dominant models have emerged: Stage-Gate (Cooper, 1990s, evolved) and Lean Startup (Ries, 2011, now standard for early-stage). Most world-class programs combine them at different stages of maturity. BCG 2024 data is instructive: companies running structured innovation programs return an average of $3.60 per $1 invested, versus $1.80 for ad-hoc innovation. That 2x difference is almost entirely attributable to explicit gating and learning discipline, not to the quality of initial ideas. Harvard Business School research (2023) confirmed that organizations using formal innovation accounting are 2.3x more likely to commercialize innovation lab outputs. DeepLearnHQ take: the programs we have seen produce real H2 outcomes consistently use a hybrid — Lean experiment design inside Stage-Gate financial governance. The gates exist, but what you bring to a gate is learning evidence, not a polished presentation.
Stage-Gate (Enterprise model). Gates investment decisions at defined checkpoints: Discovery ($50K), Alpha ($250K), Beta ($1M), Launch ($5M+). Each gate requires evidence against a pre-defined checklist before the next tranche is released. Its advantage is financial discipline and board-legible governance. Its weakness: it incentivizes teams to present positive data at gates rather than share honest learning. The fix: redesign gate criteria to explicitly reward learning-based pivots. A program that gates-and-kills 40% of ideas is healthier than one that gates-and-proceeds 90%. Lean Startup (Early-stage and H3 model). Structures innovation around explicit assumption maps and Build-Measure-Learn loops. Each experiment is designed to kill the single riskiest assumption first. Investment scales with validated learning, not with the passage of time. The risk: without financial discipline, Lean programs can produce continuous pivot cycles without ever committing to commercialization. The fix: set explicit pivot-or-persevere decision points at 8-week intervals, and define in advance what evidence would trigger commercialization.
| Model | Best Horizon | Capital Required | Time to Value | Integration Complexity | Primary Risk | Ideal Company Stage |
|---|---|---|---|---|---|---|
| Internal Innovation Lab | H1, H2 | $500K–$5M/year | 12–36 months | Low (same org) | Innovation theater; org resistance to commercializing outputs | Series B+, enterprise |
| Corporate Accelerator | H2, H3 | $1M–$10M/cohort | 18–48 months | Medium (partnership model) | Ecosystem fragmentation; poor follow-through on integration | Enterprise (>$500M revenue) |
| Corporate Venture Capital (CVC) | H3 | $10M–$100M+ fund | 5–10 years | High (acquisition or partnership required) | Patient capital; no near-term strategic return; 24% success rate (BCG) | Large enterprise ($1B+ revenue) |
| Open Innovation / Ecosystem | H2, H3 | $200K–$2M/year | 24–60 months | Variable (ecosystem-dependent) | Structural separation from core BUs; low measurable value | Platform businesses, API-led companies |
| Innovation Sprints (External Partner) | H1, H2 | $50K–$500K/sprint | 8–16 weeks | Low (vendor-delivered, team-handed-off) | No internal capability to execute on findings after engagement ends | Any stage with a specific capability gap |
The most significant shift in innovation practice in the last three years is not a new framework — it is the AI-driven compression of the innovation cycle. A fintech company running a 90-day innovation program in 2024 reported cutting their insight-to-prototype cycle from 3 weeks to 4 days by deploying Dovetail AI for research synthesis, v0 by Vercel for UI generation, and Claude for market analysis. That compression allowed them to test 6 concepts in the time previously required for 2. This is not an isolated example — it represents a structural change in what a resourced innovation team can now accomplish. AI is collapsing the time required for market research, competitive scanning, and prototype generation — three activities that previously consumed the majority of an innovation sprint's calendar time.
Brightidea. Enterprise-grade idea management platform used by Siemens, Pfizer, and NASA. Runs innovation campaigns, manages stage-gate pipelines, and tracks innovation accounting dashboards with Jira/Salesforce integration. Pricing: $50K–$200K/year enterprise contracts. Best for large organizations managing distributed innovation pipelines across business units. Planbox. Agile innovation management positioned between Brightidea and lightweight tools like Miro. Strong workflow customization with an Innovation Accounting module that maps ideas to business outcomes. Pricing: $30K–$80K/year. Best for structured portfolio management without full IT overhead. IdeaScale. More accessible entry point with an AI-powered SmartReview feature (launched 2023) that automatically clusters, scores, and surfaces high-potential ideas. Pricing: $15K–$50K/year. Popular in government and mid-market. Dovetail AI. Critical for the research synthesis phase — analyzes 50+ interview transcripts and surfaces recurring struggling moments in minutes rather than days, cutting synthesis time by approximately 60% without sacrificing insight quality. v0 by Vercel. Generates React/Tailwind UI prototypes from text prompts. Compresses the concept-to-testable-prototype phase from days to hours, enabling same-day concept testing. Crayon / Klue. Real-time competitive intelligence platforms. Crayon tracks competitor website changes, job postings, pricing updates, and press mentions with AI summarization. Eliminates the need for a dedicated analyst team doing manual competitive scanning.
AI is compressing market research, prototype generation, and insight synthesis. It is not replacing the three activities that most determine program success: problem framing (identifying which problem is worth solving requires human judgment that AI consistently underperforms on novel domains), stakeholder alignment (innovation programs die in governance, not in research — that requires organizational relationship skills), and assumption design (knowing which assumption to kill first requires strategic judgment current AI tools cannot reliably supply). A 2024 debate in the innovation community centers on whether AI-generated insights create false confidence — teams running AI-synthesized research but missing the lived reality of customers. The cautionary evidence: a 2023 Nielsen Norman Group study found that AI-generated recommendations matched expert human recommendations only 67% of the time for novel design problems, and performed worse specifically on the edge cases and outlier behaviors that most often surface breakthrough innovation insights. DeepLearnHQ take: the innovation teams deploying AI most effectively are using it to run more experiments within the same time budget — not to replace the human judgment at the front and back end of those experiments.
The most persistent governance failure in corporate innovation is measuring programs with the same metrics used to manage the core business. Revenue, growth rate, and margin are meaningless for early-stage innovation bets — applying them kills programs before they can produce results and rewards teams for presenting optimistic forecasts rather than honest learning. Innovation accounting replaces financial metrics with learning metrics during the pre-commercialization phase. Harvard Business School research (2023) confirmed that organizations using formal innovation accounting are 2.3x more likely to commercialize lab outputs. The consequence of ignoring this is the systematic destruction of H2 and H3 investment by applying the wrong filter at the wrong stage. DeepLearnHQ take: the most useful innovation metric we have found in practice is not any single KPI in isolation — it is whether the team can name the three most dangerous assumptions currently active in their innovation portfolio and describe exactly how they are testing each one.
| KPI | What It Measures | Healthy Benchmark | Warning Signal | Applies To |
|---|---|---|---|---|
| Learning Velocity | Hypotheses tested and validated/invalidated per sprint | 2–4 major assumptions per 2-week sprint | <1 assumption tested per sprint | H2, H3 |
| Pivot Rate | % of bets that pivot direction vs. persevere over 6 months | 30–50% pivot rate | 0% pivot rate signals suppressed learning | H2, H3 |
| Time-to-Validated-Insight | Days from research question to validated finding | <14 days in AI-augmented programs | >30 days per research question | All horizons |
| Idea-to-Pilot Conversion | % of pipeline ideas reaching a pilot stage | 5–15% | <5% or >15% both indicate filter miscalibration | H2, H3 |
| H2 Revenue Contribution | % of total revenue from H2 products (3-year lag) | Target 15–25% by year 5 of program | 0% after 3+ years of active H2 investment | H2 (lagging indicator) |
| Innovation ROI | Revenue generated per $1 invested in a structured program | $3.60 per $1 (BCG 2024 benchmark) | <$1.80 per $1 (ad-hoc innovation baseline) | H1, H2 (H3 too early-stage for revenue metrics) |
$2M product hitting zero growth. Found new market segment. New MVP launched 10 weeks later, growing 15% MoM.
Founder had idea but no validation. 6-week discovery revealed adjacent problem. Series A ready in 6 months.
Prototype is throwaway code. Proves the idea works. Looks real. Can't scale. 40-80 hours. MVP is real code. Shipped to users. Scalable. Maintainable. 8-12 weeks. Start with prototype. Only build MVP if prototype validates the core hypothesis.
Discovery costs $15K-$35K and takes 2-3 weeks. Includes 30-40 user interviews, competitive analysis, and a go/no-go recommendation. Most companies spend 10x this on building the wrong product.
Yes. We've helped successful products find new markets, new user segments, and new revenue models. Sometimes a successful product is just a feature of something bigger. We help you see it.
Both. We embed agile coaches with teams. We teach sprint planning, retrospectives, and feedback loops. Your team learns while we build. By project end, you don't need us. You ship fast on your own.
Good. You learned something. Now you pivot or kill it. The MVP cost you $80-150K and 12 weeks. A full product would have cost $500K-$2M and 6 months. You made the right bet even if it lost.
Not by features shipped. By learning. Did you test your assumption? Did users validate it? Can you explain why it worked or didn't? Best product decisions are made with data, not opinions.
Tell us about your problem. We'll give you an honest read on scope, approach, and whether we're the right team.